0001193125-18-209703.txt : 20180629 0001193125-18-209703.hdr.sgml : 20180629 20180629161906 ACCESSION NUMBER: 0001193125-18-209703 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180625 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20180629 DATE AS OF CHANGE: 20180629 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dolby Laboratories, Inc. CENTRAL INDEX KEY: 0001308547 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 900199783 STATE OF INCORPORATION: DE FISCAL YEAR END: 0924 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32431 FILM NUMBER: 18929511 BUSINESS ADDRESS: STREET 1: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 415 558 0200 MAIL ADDRESS: STREET 1: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 8-K 1 d864662d8k.htm 8-K 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 25, 2018

 

 

DOLBY LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-32431   90-0199783

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

1275 Market Street

San Francisco, CA 94103-1410

(Address of principal executive offices) (Zip Code)

(Registrant’s telephone number, including area code) (415) 558-0200

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Section 8 – Other Events

 

ITEM 8.01 Other Events

A statement from the Board of Directors of Dolby Laboratories, Inc. regarding the passing of Board member Nicholas Donatiello, Jr. is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Section 9 – Financial Statements and Exhibits

 

ITEM 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit

   No.   

  

Description

99.1    Statement of the Board of Directors of Dolby Laboratories, Inc. dated June 29, 2018


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  DOLBY LABORATORIES, INC.
By:   /s/ ANDY SHERMAN
 

Andy Sherman

Executive Vice President, General Counsel, and Corporate Secretary

Date: June 29, 2018

EX-99.1 2 d864662dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Statement by Dolby Laboratories, Inc.’s Board of Directors

Regarding the Passing of Nicholas Donatiello, Jr.

SAN FRANCISCO, June 29, 2018 – (NYSE: DLB) – It is with deep sadness that we announce the passing of Nicholas Donatiello, Jr., our fellow Board member at Dolby Laboratories, Inc. Nick was an industry leader and close friend who will be greatly missed by his colleagues at Dolby, its stockholders and business partners. Our thoughts and prayers are with his family during this difficult time.

“Nick was a dear friend, a valued member of Dolby’s board, and a distinguished voice in the field of corporate governance,” said Peter Gotcher, Chairman of Board of Directors of Dolby Laboratories. “We are deeply grateful for his many years of service, advice, and contributions to the company and its stockholders.”

Mr. Donatiello was a member of the Board of Directors since 2009 and served as the Chairman of the Compensation Committee and a member of the Nominating and Governance Committee and the Technology Strategy Committee.

About Dolby Laboratories

Dolby Laboratories (NYSE: DLB) is based in San Francisco with offices in over 20 countries around the globe. Dolby transforms the science of sight and sound into spectacular experiences. Through innovative research and engineering, we create breakthrough experiences for billions of people worldwide through a collaborative ecosystem spanning artists, businesses, and consumers. The experiences people have - in Dolby Vision, Dolby Atmos, Dolby Cinema, Dolby Voice, and Dolby Audio - revolutionize entertainment and communications at the cinema, on the go, in the home, and at work.

Investor Contact:

Elena Carr

Dolby Laboratories

415-645-5583

investor@dolby.com

Media Contact:

Jennifer Bowcock

Dolby Laboratories

408-768-8221

jennifer.bowcock@dolby.com